down arrow

Aarti Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE767A01016
  • NSEID: AARTIDRUGS
  • BSEID: 524348
INR
328.45
3.45 (1.06%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 64.71 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

325.80335.00

52 Week

312.50634.90
Valuation
Technical
Day's Volume

CASH

64.71 k (-50.29%) Volume

Shareholding (Dec 2024)

FII

2.28%

Held by 79 FIIs

DII

8.77%

Held by 10 DIIs

Promoter

55.38%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 5.12% and Operating profit at 2.46% over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 3,020 Cr (Small Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.31%

stock-summary
Debt Equity

0.45

stock-summary
Return on Equity

11.92%

stock-summary
Price to Book

2.34

Revenue and Profits (1 Year):
Net Sales:
557 Cr
(Quarterly Results - Dec 2024)
Net Profit:
37 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.31%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-35.47%
0.21%
-35.26%
1 Year
-35.28%
0.20%
-35.08%
2 Years
-17.08%
0.45%
-16.63%
3 Years
-36.55%
0.71%
-35.84%
4 Years
-55.24%
0.53%
-54.71%
5 Years
103.82%
3.05%
106.87%

Latest dividend: 1 per share ex-dividend date: Feb-04-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.12%
EBIT Growth (5y)
2.46%
EBIT to Interest (avg)
10.29
Debt to EBITDA (avg)
1.55
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.57
Tax Ratio
25.47%
Dividend Payout Ratio
5.36%
Pledged Shares
0
Institutional Holding
11.05%
ROCE (avg)
19.36%
ROE (avg)
19.21%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
33
Price to Book Value
2.34
EV to EBIT
15.84
EV to EBITDA
12.75
EV to Capital Employed
1.92
EV to Sales
1.53
PEG Ratio
NA
Dividend Yield
0.31%
ROCE (Latest)
12.66%
ROE (Latest)
11.92%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (7.78%)

FIIs

Held by 79 FIIs (2.28%)

Promoter with highest holding

Prakash Moreshwar Patil (9.23%)

Highest Public shareholder

Dsp Small Cap Fund (6.45%)

Individual Investors Holdings

24.32%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -6.97% vs 7.74% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 5.83% vs 5.32% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "556.60",
          "val2": "598.33",
          "chgp": "-6.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.72",
          "val2": "67.05",
          "chgp": "-7.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.07",
          "val2": "8.93",
          "chgp": "1.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.05",
          "val2": "35.01",
          "chgp": "5.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.09%",
          "val2": "11.21%",
          "chgp": "-0.12%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -11.44% vs -0.54% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -21.95% vs 18.90% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,153.67",
          "val2": "1,302.64",
          "chgp": "-11.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "132.01",
          "val2": "160.51",
          "chgp": "-17.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.64",
          "val2": "16.79",
          "chgp": "5.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "68.25",
          "val2": "87.44",
          "chgp": "-21.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.44%",
          "val2": "12.32%",
          "chgp": "-0.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -10.39% vs -3.30% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -15.16% vs 12.60% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,710.27",
          "val2": "1,908.58",
          "chgp": "-10.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "193.73",
          "val2": "230.65",
          "chgp": "-16.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "26.71",
          "val2": "24.39",
          "chgp": "9.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "105.30",
          "val2": "124.11",
          "chgp": "-15.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.33%",
          "val2": "12.08%",
          "chgp": "-0.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -6.90% vs 9.14% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 3.07% vs -18.89% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,528.58",
          "val2": "2,716.05",
          "chgp": "-6.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "316.46",
          "val2": "305.60",
          "chgp": "3.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "33.52",
          "val2": "33.29",
          "chgp": "0.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "171.42",
          "val2": "166.31",
          "chgp": "3.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.52%",
          "val2": "11.25%",
          "chgp": "1.27%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
556.60
598.33
-6.97%
Operating Profit (PBDIT) excl Other Income
61.72
67.05
-7.95%
Interest
9.07
8.93
1.57%
Exceptional Items
0.00
0.00
Consolidate Net Profit
37.05
35.01
5.83%
Operating Profit Margin (Excl OI)
11.09%
11.21%
-0.12%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -6.97% vs 7.74% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 5.83% vs 5.32% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,153.67
1,302.64
-11.44%
Operating Profit (PBDIT) excl Other Income
132.01
160.51
-17.76%
Interest
17.64
16.79
5.06%
Exceptional Items
0.00
0.00
Consolidate Net Profit
68.25
87.44
-21.95%
Operating Profit Margin (Excl OI)
11.44%
12.32%
-0.88%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -11.44% vs -0.54% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -21.95% vs 18.90% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,710.27
1,908.58
-10.39%
Operating Profit (PBDIT) excl Other Income
193.73
230.65
-16.01%
Interest
26.71
24.39
9.51%
Exceptional Items
0.00
0.00
Consolidate Net Profit
105.30
124.11
-15.16%
Operating Profit Margin (Excl OI)
11.33%
12.08%
-0.75%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -10.39% vs -3.30% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -15.16% vs 12.60% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2,528.58
2,716.05
-6.90%
Operating Profit (PBDIT) excl Other Income
316.46
305.60
3.55%
Interest
33.52
33.29
0.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
171.42
166.31
3.07%
Operating Profit Margin (Excl OI)
12.52%
11.25%
1.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -6.90% vs 9.14% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 3.07% vs -18.89% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Aarti Drugs Ltd stock-summary
stock-summary
Aarti Drugs Ltd
Small Cap
Pharmaceuticals & Drugs
Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million. With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
Company Coordinates stock-summary
Company Details
Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal Thane Maharashtra : 401506
stock-summary
Tel: 91-22-24072249
stock-summary
http://www.aartidrugs.com
stock-summary
investorrelations@aartidrugs.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."